MedPath

Effectiveness of Unani Drugs in High Blood Pressure

Phase 2
Conditions
Health Condition 1: null- Essential Hypertension (Zaght al-Dam Qawi Lazimi)
Registration Number
CTRI/2017/12/011006
Lead Sponsor
Central Research Institute of Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All subjects will meet the following criteria:

1-Patients of any sex in the age group of 35 to 55 years

2-Patients having Stage-I Hypertension according to JNC-8 (Systolic BP 140-159 and

Diastolic BP 90-99 mmHg) with or without the following symptoms:

3-Suda (Headache)

4-Khafaqan (Palpitation)

5-Kasal (Laziness)

6-Qalaq (Anxiety)

7-Usr al-Tanaffus (Breathlessness)

8-Nabz Mumtali (Pulsus plenus)

9-Clinically stable patients

10-Patients not taking any anti-hypertensive drugs

11-Patients willing to sign the informed consent form

Exclusion Criteria

Patients will be excluded if they meet any of the following criteria:

1-Patient with SBP >=160 mmHg and DBP >=100 mmHg

2-Patients of Secondary Hypertension

3-Pregnant and Lactating women

4-Obese subjects â?? BMI >30

5-Drug Addicts, Alcoholics

6-Patients not willing to give consent

7-Patients not willing to come for follow-up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath